• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues and Friends,

On behalf of the Local Organizing Committee, the International Papillomavirus Society (IPVS), and the Asia-Oceania Research Organisation in Genital Infection and Neoplasia (AOGIN), we are very pleased to invite you to participate in the 32nd International Papillomavirus Conference & Clinical and Public Health Workshops that will be held in Sydney, Australia from October 2nd-6th 2018.

We are excited to host the 2018 meeting in Sydney, Australia. Australia has been at the forefront of HPV research from key innovations in immunology and vaccine development through to the implementation of large scale vaccination initiatives and an upcoming imminent transition to HPV-based cervical screening. We are also very pleased to be co-hosting the meeting with AOGIN, and plan a strong regional focus on HPV control in the Asia-Pacific Region. 

Our conference theme is 'Towards Global Control of HPV Disease' and through workshops, invited lectures, and oral and poster sessions presenting the latest research results, the conference will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV control in populations that are most vulnerable to HPV disease worldwide, including those in Low and Middle Income Countries and Indigenous communities.

In line with the IPVS mission of addressing the most recent advances across the spectrum of PV research, conference themes will also include the epidemiology and molecular biology of PVs; animal models for the study of papillomavirus disease; impact of the microbiome on HPV; basic immunology and pathogenesis of PVs; therapeutic and prophylactic vaccines; prevention of cervical cancer and other PV-associated diseases, and promotion of the spread of the scientific knowledge to benefit the whole community. Our overarching theme will be harnessing the power of innovation in HPV to deliver global control of HPV-related disease.

Sydney is a beautiful city – and our conference will be held at the brand new Sydney International Convention Centre on the Harbour. Please do join us in what promises to be a most extraordinary event!

Yours sincerely,

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Submission Info

Abstract submission deadline 2018-04-17

Before you begin, please prepare the following information:

1. Presenting author's contact details:

Email address

Full first and family name(s).

Affiliation details: department, institution / hospital, city, state (if relevant), country

2. Co-authors' contact details:

​​Email address

​Full first and family name(s).

Affiliation details: department, institution / hospital, city, state (if relevant), country​

​3. Abstract title: Limited to 25 words in UPPER CASE

4. Abstract text: Limited to 250 words. ​We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.

5. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract A maximum of 3 images can be included per abstract.

The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG format only.

After you submit your abstract, you can re-enter the submission link at any time to view and edit your abstract until the deadline date. Submitted abstracts cannot be modified or corrected after the submission deadline. There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.​​

SUBMISSION OF ABSTRACTS

​Only abstracts submitted via the online submission form will be sent to the Abstract Review Committee for review.

Abstracts submitted by fax or e-mail will not be accepted.

Please do not submit multiple copies of the same abstract.

The Committee will endeavor to schedule abstracts according to authors’ preferences but reserves the right to decide on the final form of presentation.

A confirmation email will be sent to you when your abstract has been received. Please refer to your abstract by number, title and presenting author in all correspondence regarding the abstract.

Please contact the Secretariat if you have not received confirmation that your abstract has been received.

All abstracts will be forwarded to the Committee for review. Notifications regarding status will be sent once the review process is complete.

Abstracts may be edited by the Scientific Program Committee before publication.

The presenting author is expected to attend and register for IPVC 2018 Conference by the communicated registration deadline and present the poster or oral presentation. 

The presenting author is requested to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.

Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.

RULES FOR SUBMISSION

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.

Presenting authors must be registered participants. Registration fees must be received by the Secretariat by July 10, 2018 to ensure inclusion of the abstract in the abstracts USB and in order to be scheduled for presentation.

The Scientific Committee will determine whether abstracts will be accepted as oral or poster presentations, with consideration to be given to the author's preference. Abstracts will be reviewed and assigned to appropriate sessions.

All submitted abstracts must contain novel data. Abstracts stating "data will be discussed in the presentation" will NOT be accepted.

The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.​​

ABSTRACT SUBMITTERS' DECLARATION

BEFORE SUBMITTING THE ABSTRACT, THE ABSTRACT SUBMITTER WILL BE REQUIRED TO CONFIRM THE FOLLOWING:

1. I, the Abstract Submitter, confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.​

2. Submission of the abstract constitutes my consent to publication (e.g. congress website, programs, other promotions, etc.)

3. I, the Abstract Submitter, warrant and represent that I am the sole owner or have the rights of all the information and content ("Content") provided to the International Congress on Autoimmunity and Kenes International (Hereafter: “The Organizers"). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. 

4. I, the Abstract Submitter, grant the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.

5. The Organizers reserve the right to remove from any publication an abstract which does not comply with the above.

6. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract

 GPC

KEEP ME UPDATED

example@example.com

 SUBSCRIBE

Bring together the world's scientific experts to catalyze and advance scientific knowledge of papillomavirus (PV)-related topics present the most recent research findings, promote and enhance scientific collaborations around the world.

Through workshops, invited lectures, and oral and poster sessions present the latest research results

The conference will cover papillomavirus (PV)-related topics from basic science to global health impact

Industry Benefits of Supporting IPVC 2018

Demonstrate your company’s leadership in the field of papillomavirus

 Raise your company’s visibility in the field

A truly international meeting allowing interactions with worldwide KOL's

A unique opportunity to exchange ideas with renowned professionals from across the world

An ideal networking forum

Convene a corporate symposium​

 IPVS Secretariat , Kenes Group

Phone: +41-22-908-0488

Email: lprodanova@kenes.com